Helpline01322 619898


Allergy is the most common chronic disease in Europe. Up to 20% of patients with allergies struggle daily with the fear of a possible asthma attack, anaphylactic shock, or even death from an allergic reaction

(EAACI, 2016)


    • The World Allergy Organisation (WAO) estimate of allergy prevalence of the whole population by country ranges between 10 - 40% (Pawankar R, et al, 2013)
    • More than 150 million Europeans suffer from chronic allergic diseases and the current prediction is that by 2025 half of the entire EU population will be affected (EAACI, 2016)

In the UK

    • The UK has some of the highest prevalence rates of allergic conditions in the world, with over 20% of the population affected by one or more allergic disorder. (M. L. Levy, 2004)
    • A staggering 44% of British adults now suffer from at least one allergy and the number of sufferers is on the rise, growing by around 2 million between 2008 and 2009 alone. Almost half (48%) of sufferers have more than one allergy (Mintel, 2010)
    • In the 20 years to 2012 there was a 615% increase in the rate of hospital admissions for anaphylaxis in the UK (Turner, Paul J., et al, 2015)


    • With a life time prevalence of 15-30% in children and 2-10% in adults, the incidence of AE has increased by two- to threefold in industrialized countries during the past three decades (Pawankar R, et al, 2013)
    • In 45% of children, the onset of Atopic Eczema occurs during the first 6 months of life; during
      the first year 60% of these children are affected, and 85% are affected before the age of five (Pawankar R, et al, 2013)


    • It is estimated by the World Health Organisation that 300 million individuals have asthma worldwide, and that with current rising trends this will reach 400 million by 2025. Approximately 250,000 people die prematurely each year from asthma; almost all these deaths are avoidable (Pawankar R, et al, 2013)
    • 5.4 million People in the UK are currently receiving treatment for asthma: 1.1 million children (1 in 11) and 4.3 million adults (1 in 12). (Asthma UK, 2017)


    • Anaphylaxis-type reactions occur in approximately 1 in 1000 of the general population. Anaphylaxis during general anaesthesia occurs in 1 in 10,000–20,000 anaesthetics. These patients may be denied general anaesthesia in the future unless a safe combination of drugs can be identified (NICE , 2014)

Allergic Rhinitis (Hay Fever)

  • Allergic rhinitis is the most common form of non-infectious rhinitis, affecting between 10% and 30% of all adults and as many as 40% of children (Pawankar R, et al, 2013)
  • Up to 57% of adult patients and up to 88% of children with AR have sleep problems, including micro-arousals, leading to daytime fatigue and somnolence, and decreased cognitive functioning (Pawankar R, et al, 2013)